Corvus Pharmaceuticals, Inc. (CRVS)

NASDAQ: CRVS · IEX Real-Time Price · USD
0.960
+0.044 (4.80%)
At close: Aug 8, 2022 4:00 PM
0.900
-0.060 (-6.250%)
After-hours: Aug 8, 2022 7:45 PM EDT

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017201620152014
Net Income
-43.24-6-46.67-46.94-55.66-36.38-31.34-0.16
Depreciation & Amortization
0.460.630.740.850.840.590.150
Share-Based Compensation
4.235.757.357.146.233.830.430
Other Operating Activities
1.83-35.161.26-2.032.384.119.430.07
Operating Cash Flow
-36.72-34.78-37.32-40.99-46.21-27.86-11.33-0.1
Capital Expenditures
-0.01-0.08-0.03-0.36-0.27-2.2-1.750
Change in Investments
21.5744.853.28-29.8485.09-40.36-90.290
Investing Cash Flow
21.5644.773.26-30.1984.83-42.56-92.030
Share Issuance / Repurchase
62.161.310.0265.271.4471.360.110
Other Financing Activities
00000094.8412.61
Financing Cash Flow
62.161.310.0265.271.4471.3694.9512.61
Net Cash Flow
4711.3-34.04-5.9140.060.95-8.4112.52
Free Cash Flow
-36.72-34.85-37.35-41.34-46.48-30.06-13.08-0.1
Free Cash Flow Per Share
-0.88-1.18-1.27-1.50-2.27-1.95-34.99-0.56
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).